Results 221 to 230 of about 350,628 (274)
This study identifies FXYD1 as an epigenetically silenced tumor suppressor in breast cancer. DNA methylation turns off the gene FXYD1 in breast cancer, and low levels predict worse outcomes. Restoring FXYD1 limits breast cancer cells proliferation and metastasis. In the nucleus, FXYD1 recruits the E3 ligase MAEA to K63‐ubiquitinate DDX5 for proteasomal
Ping Wen +11 more
wiley +1 more source
When Stability Fails: Rare Very Late Dislodgement of 3830 Lead. [PDF]
Kumar D +5 more
europepmc +1 more source
Tumor dsDNA released by cryoablation is taken up by macrophages, activating the cGAS‐STING signaling pathway. This leads to an expansion of the CXCL10+ macrophage pool and increased secretion of CXCL10, which in turn recruits CXCR3+ T cells from draining lymph nodes into the tumor microenvironment to exert anti‐tumor effects.
Xinxin Zhi +17 more
wiley +1 more source
From Technical Pitfall to Clinical Consequences: Leadless Pacing as a Rescue Solution. [PDF]
Cacciapuoti F +5 more
europepmc +1 more source
Standard work tools for managing pediatric baclofen pump infections and withdrawal. [PDF]
Jain R +4 more
europepmc +1 more source
Toward a science of human-AI teaming for decision making: A complementarity framework. [PDF]
Gonzalez C +7 more
europepmc +1 more source
Pheochromocytoma presenting as suspected peripartum cardiomyopathy with ventricular tachyarrhythmias. [PDF]
Talbot N, Kyrouac D, Patel N.
europepmc +1 more source

